INDRAMEDCO

INDRAPRASTHA MEDICAL CORPORATION

Small Cap BSE: 532150 NSE: INDRAMEDCO
₹83.65
-1.45 (-1.7%)
As on 06 December, 2022 | 22:50

Indraprastha Medical Corporation Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in INDRAPRASTHA MEDICAL CORPORATION

Start SIP

Indraprastha Medical Corporation Share Price

Indraprastha Medical Corporation Share Returns

  • Over 1 Month 14.75%
  • Over 3 Month 15.86%
  • Over 6 Month 42.14%
  • Over 1 Year 3.21%

Indraprastha Medical Corporation Key Statistics

P/E Ratio 10
PEG Ratio 0.2
Market Cap Cr 767
Price to Book Ratio 2.4
EPS 6.9
Dividend 3
Relative Strength Index 56.15
Money Flow Index 35.48
MACD Signal 3.83
Average True Range 3.44

Indraprastha Medical Corporation Investment Rating

  • Master Rating:
  • Indraprastha Med. (Nse) Corp. has an operating revenue of Rs. 1,000.04 Cr. on a trailing 12-month basis. An annual revenue growth of 45% is outstanding, Pre-tax margin of 9% is okay, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 14% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 61 which is a FAIR score but needs to improve its earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 51 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Indraprastha Medical Corporation Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 284263216237233203198
Operating Expenses Qtr Cr 241226188205208173168
Operating Profit Qtr Cr 44372831253030
Depreciation Qtr Cr 101099998
Interest Qtr Cr 1111111
Tax Qtr Cr 9756456
Net Profit Qtr Cr 25201516121515

Indraprastha Medical Corporation Technicals

EMA & SMA

Current Price
83.65
-1.45 (-1.7%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 83.19
  • 50 Day
  • 77.12
  • 100 Day
  • 72.08
  • 200 Day
  • 69.44
  • 20 Day
  • 86.09
  • 50 Day
  • 73.52
  • 100 Day
  • 69.33
  • 200 Day
  • 65.47

Indraprastha Medical Corporation Resistance and Support

PIVOT
₹85.44
Resistance
First Resistance 86.67
Second Resistance 88.24
Third Resistance 89.47
RSI 56.15
MFI 35.48
MACD Single Line 3.83
MACD 2.82
Support
First Resistance 83.87
Second Resistance 82.64
Third Resistance 81.07

Indraprastha Medical Corporation Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 150,284 15,028,400 100
Week 313,550 18,562,148 59.2
1 Month 874,522 41,189,979 47.1
6 Month 284,548 14,688,379 51.62

Indraprastha Medical Corporation Result Highlights

Indraprastha Medical Corporation Synopsis

NSE-Medical-Hospitals

Indraprastha Med belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 888.16 Cr. and Equity Capital is Rs. 91.67 Cr. for the Year ended 31/03/2022. Indraprastha Medical Corporation Ltd. is a Public Limited Listed company incorporated on 16/03/1988 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1988PLC030958 and registration number is 030958.
Market Cap 767
Sales 1,000
Shares in Float 4.49
No of funds 8
Yield 2.94
Book Value 2.35
U/D Vol ratio 1.7
LTDebt / Equity
Alpha
Beta 0.98

Indraprastha Medical Corporation

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 51%51%51%
Mutual Funds
Foreign Portfolio Investors 0.15%0.09%0.14%
Financial Institutions/ Banks 0.02%0.02%0.02%
Individual Investors 31.25%31.4%31.6%
Others 17.58%17.49%17.24%

Indraprastha Medical Corporation Management

Name Designation
Mr. Jasmine Shah Chairman
Dr. Prathap C Reddy Vice Chairman
Mr. P Shivakumar Managing Director
Mr. Deepak Vaidya Director
Mr. Satnam Arora Director
Mr. S Regunathan Director
Ms. Suneeta Reddy Director
Mr. Vinayak Chatterjee Director
Ms. Vineeta Rai Director
Ms. Madhumita Ganguli Director
Dr. Menaka Guruswami Director
Ms. Sangita Reddy Director
Dr. Arun Rai Director
Prof. (Dr) Mahesh Verma Director
Mr. Salil Singhal Director
Mr. Udit Prakash Rai Director
Mr. Vikram Bhat Director

Indraprastha Medical Corporation Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Indraprastha Medical Corporation Corporate Action

Date Purpose Remarks
2022-11-04 Quarterly Results
2022-08-08 Quarterly Results
2022-02-08 Quarterly Results
2021-11-09 Quarterly Results
2021-08-09 Quarterly Results

Indraprastha Medical Corporation MF Shareholding

Name Amount(cr)
Motilal Oswal S&P BSE Healthcare ETF 6

Indraprastha Medical Corporation FAQs

What is Share Price of Indraprastha Medical Corporation ?

Indraprastha Medical Corporation share price is ₹83 As on 06 December, 2022 | 22:36

What is the Market Cap of Indraprastha Medical Corporation ?

The Market Cap of Indraprastha Medical Corporation is ₹766.8 Cr As on 06 December, 2022 | 22:36

What is the P/E ratio of Indraprastha Medical Corporation ?

The P/E ratio of Indraprastha Medical Corporation is 10 As on 06 December, 2022 | 22:36

What is the PB ratio of Indraprastha Medical Corporation ?

The PB ratio of Indraprastha Medical Corporation is 2.4 As on 06 December, 2022 | 22:36

Q2FY23